Merck just announced that it granted a royalty-free license for its antiviral drug molnupiravir to Medicines Patent Pool, a United Nations-backed organization dedicated to providing crucial medicines to 105 poorer countries. Will this make a difference in the battle against COVID? I argue that it will.
Emergency Use Authorization (EUA) from the FDA is the exception, not the rule. Except for COVID therapies. Three vaccines and one drug have EUA in the US. Merck is now seeking EUA for its antiviral drug molnupiravir. Should it be granted?
Shingles, also called herpes zoster, is a reactivation of the dormant chickenpox virus in the body. Often, this reactivation that leads to the disease occurs years or even decades after a chickenpox infection. The first symptoms of shingles are extreme sensitivity or pain in a
The Advisory Committee on Immunization Practices recommends that all boys and girls receive the HPV vaccine before they become sexually active. Currently, there are two HPV vaccines approved
For children in the developed world (and their parents), rotavirus a childhood equivalent to norovirus (the stomach flu) is very unpleasant, but usually self-limiting.